X0306 4 2017-08-06 0 0001512762 Coherus BioSciences, Inc. CHRS 0001242116 FINCK BARBARA K COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 0 1 0 0 Chief Medical Officer Common Stock, $0.0001 par value 26791 D Stock Option (Right to Buy) 12.70 2017-08-06 4 A 0 67000 0.00 A 2027-08-06 Common Stock 67000 67000 D The underlying shares subject to the option vest and become exercisable as to (i) fifty percent (50%) of the total number of shares subject to the option after one year measured from August 1, 2017 (the "Vesting Commencement Date"), (ii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the eighteen (18) month anniversary of the Vesting Commencement Date and (iii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the two year anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Jean-Frederic Viret, as Attorney-in-Fact for Barbara K. Finck, M.D. 2017-08-08